A Bayesian network meta-analysis on the effect of inodilatory agents on mortality

British Journal of Anaesthesia

Volumn 114, Issue 5, 2015, Pages 746-756

  Greco, T ^a   Calabro M G ^a   Covello, R D ^a   Greco, M ^a   Pasin, L ^a   Morelli, A ^b   Landoni, G ^a   Zangrillo, A ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

anaesthesia meta analysis; anaesthetics i.v.; cardiovascularanaesthesia; surgery Cardiovascular

Indexed keywords

DOBUTAMINE; ENOXIMONE; INOTROPIC AGENT; LEVOSIMENDAN; MILRINONE; PLACEBO; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN; VASODILATOR AGENT;

BAYES THEOREM; BIOMED CENTRAL; COCHRANE LIBRARY; DRUG EFFICACY; EMBASE; FOLLOW UP; HEART SURGERY; HUMAN; MEDLINE; META ANALYSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY ANALYSIS; SURGICAL MORTALITY; SURGICAL PATIENT; SURVIVAL; CRITICAL ILLNESS; MORTALITY;

BAYES THEOREM; CARDIAC SURGICAL PROCEDURES; CRITICAL ILLNESS; DOBUTAMINE; ENOXIMONE; HUMANS; HYDRAZONES; MILRINONE; PYRIDAZINES; VASODILATOR AGENTS;

EID: 84928891158     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeu446     Document Type: Review

References (62)

1. Gillies M, Bellomo R, Doolan L, Buxton B. Bench-to-bedside review: Inotropic drug therapy after adult cardiac surgery - A systematic literature review. Crit Care 2005; 9: 266-79
2. Fellahi JL, Fischer MO, Daccache G, Gerard JL, Hanouz JL. Positive inotropic agents in myocardial ischemia-reperfusion injury: a benefit/risk analysis. Anesthesiology 2013; 118: 1460-5
3. Fellahi JL, Parienti JJ, Hanouz JL, Plaud B, Riou B, Ouattara A. Perioperative use of dobutamine in cardiac surgery and adverse cardiac outcome: propensity-adjusted analyses. Anesthesiology 2008; 108: 979-87
4. Shahin J, DeVarennes B, TseCW, AmaricaDA, Dial S. The relationship between inotrope exposure, six-hour postoperative physiological variables, hospital mortality and renal dysfunction in patients undergoing cardiac surgery. Crit Care 2011; 15: R162
5. Nielsen DV, Hansen MK, Johnsen SP, Hansen M, Hindsholm K, Jakobsen CJ. Health Outcomes with and without Use of Inotropic Therapy in Cardiac Surgery: Results of a Propensity Score-matched Analysis. Anesthesiology 2014; 120: 1098-108
6. Baker SG, Kramer BS. The transitive fallacy for randomized trials: if A bests B and B bests C in separate trials, is A better than C? BMC Med Res Methodol 2002; 2: 13
7. Song F, Altman DG, Glenny AM, Deeks JJ. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ 2003; 326: 472
8. Biondi-Zoccai GG, Agostoni P, Abbate A, Testa L, Burzotta F.Asimple hint to improve Robinson and Dickersin's highly sensitive PubMed search strategy for controlled clinical trials. Int J Epidemiol 2005; 34: 224-5
9. Abacilar AF, Dogan OF. Levosimendan use decreases atrial fibrillation in patients after coronary artery bypass grafting: a pilot study. Heart Surg Forum 2013; 16: E287-94
10. Al-Shawaf E, Ayed A, Vislocky I, Radomir B, Dehrab N, Tarazi R. Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery. J Cardiothorac Vasc Anesth 2006; 20: 353-7
11. Alvarez J, Taboada M, Rodríguez J, et al. Hemodynamic effects of levosimendan following cardiac surgery. Rev Esp Anestesiol Reanim 2005; 52: 389-94
12. Alvarez J, Bouzada M, Fernández AL, et al. Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery. Rev Esp Cardiol 2006; 59: 338-45
13. Arbeus M, Axelsson B, Friberg O, Magnuson A, Bodin L, Hultman J. Milrinone increases flow in coronary artery bypass grafts after cardiopulmonary bypass: a prospective, randomized, double-blind, placebo-controlled study. J Cardiothorac VascAnesth 2009; 23: 48-53
14. Barisin S, Husedzinovic I, Sonicki Z, Bradic N, Barisin A, Tonkovic D. Levosimendan in off-pump coronary artery bypass: a four-times masked controlled study. J Cardiovasc Pharmacol 2004; 44: 703-8
15. Bautin A. Efficacy of levosimendan pretreatment in high risk cardiac surgery patients. Interact Cardiovasc Thorac Surg 2011 Abstract C4-2 available at http://icvts.oxfordjournals.org/content/ 12/Supplement-1/iv.full (accessed December 2014)
16. Baysal A, Yanartas M, Dogukan M, Gundogus N, Kocak T, Koksal C. Levosimendan Improves Renal Outcome in Cardiac Surgery: A Randomized Trial. J Cardiothorac Vasc Anesth 2014; 28: 586-94
17. Carmona MJ, Martins LM, Vane MF, Longo BA, Paredes LS, Malbouisson LM. Comparison of the effects of dobutamine and milrinoneonhemodynamic parametersand oxygen supply in patients undergoing cardiac surgery with low cardiac output after anesthetic induction. Rev Bras Anestesiol 2010; 60: 237-46
18. Couture P, Denault AY, Pellerin M, Tardif JC. Milrinone enhances systolic, but not diastolic function during coronary artery bypass grafting surgery. Can J Anaesth 2007; 54: 509-22
19. De Hert SG, Lorsomradee S, Cromheecke S, Van der Linden PJ. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anesth Analg 2007; 104: 766-73
20. Doolan LA, Jones EF, Kalman J, Buxton BF, Tonkin AM. A placebocontrolled trial verifying the efficacy of milrinone in weaning highrisk patients from cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1997; 11: 37-41
21. Ensinger H, Rantala A, Vogt J, Georgieff M, Takala J. Effect of dobutamine on splanchnic carbohydrate metabolism and amino acid balance after cardiac surgery.Anesthesiology 1999; 91: 1587-95
22. Erb J, Beutlhauser T, Feldheiser A, et al. Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery. J Int Med Res 2014; 42: 750-64
23. Eriksson HI, Jalonen JR, Heikkinen LO, et al. Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function. Ann Thorac Surg 2009; 87: 448-54
24. Ersoy O, Boysan E, Unal EU, et al. Effectiveness of prophylactic levosimendan in high-risk valve surgery patients. Cardiovasc J Afr 2013; 24: 260-4
25. Feneck RO, Sherry KM, Withington PS, Oduro-Dominah A. European Milrinone Multicentre Trial Group. Comparison of thehemodynamic effects of milrinone with dobutamine in patients after cardiac surgery. J Cardiothorac Vasc Anesth 2001; 15: 306-15
26. Gandham R, Syamasundar A, Ravulapalli H, et al. A comparison of hemodynamic effects of levosimendan and dobutamine in patients undergoing mitral valve repair/replacement for severe mitral stenosis. Ann Card Anaesth 2013; 16: 11-5
27. Hachenberg T, Möllhoff T, Holst D, Hammel D, Brüssel T. Cardiopulmonary effects of enoximone or dobutamine and nitroglycerin on mitral valve regurgitation and pulmonary venous hypertension. J Cardiothorac Vasc Anesth 1997; 11: 453-7
28. Hadadzadeh M, Hosseini SH, Mostafavi Pour Manshadi SM, et al. Effect of milrinone on short term outcome of patients withmyocardialdysfunction undergoingoff-pumpcoronaryarterybypass graft: a randomized clinical trial. Acta Med Iran 2013; 51: 681-6
29. Hayashida N, Kawara T, Tomoeda H, et al. Influence of milrinone on internal mammary artery grafts. Kyobu Geka 1999; 52: 993-7
30. Husedzinović I, Barisin S, Bradić N, Barisin A, Sonicki Z, Milanović R. Levosimendan as a new strategy during off-pump coronary artery bypass grafting: double-blind randomized placebo-controlled trial. Croat Med J 2005; 46: 950-6
31. Järvelä K, Maaranen P, Sisto T, Ruokonen E. Levosimendan in aortic valve surgery: cardiac performance and recovery. J Cardiothorac Vasc Anesth 2008; 22: 693-8
32. Jebeli M, Ghazinoor M, Mandegar MH, et al. Effect of milrinone on short-term outcome of patients with myocardial dysfunction undergoing coronary artery bypass graft: A randomized controlled trial. Cardiol J 2010; 17: 73-8
33. Jo HR, LeeWK, KimYH, et al. The effect of milrinone infusion on right ventricular function during coronary anastomosis and early outcomes in patients undergoing off-pump coronary artery bypass surgery. Korean J Anesthesiol 2010; 59: 92-8
34. Kodalli RK, Sundar AS, Vakamudi M, et al. Effect of levosimendan on hemodynamic changes in patients undergoing off-pump coronary artery bypass grafting: a randomized controlled study. Ann Card Anaesth 2013; 16: 94-9
35. Kwak YL, OhYJ, Shinn HK, Yoo KJ, Kim SH, HongYW. Haemodynamic effects of a milrinone infusion without a bolus in patients undergoing off-pump coronary artery bypass graft surgery. Anaesthesia 2004; 59: 324-31
36. Lahtinen P, Pitkänen O, Pölönen P, Turpeinen A, Kiviniemi V, Uusaro A. Levosimendan reduces heart failure after cardiac surgery: a prospective, randomized, placebo-controlled trial. Crit Care Med 2011; 39: 2263-70
37. Lee JH, Oh YJ, Shim YH, Hong YW, Yi G, Kwak YL. The effect of milrinoneonthe right ventricular function in patients with reduced right ventricular function undergoing off-pump coronary artery bypass graft surgery. J Korean Med Sci 2006; 21: 854-8
38. Leppikangas H, Järvelä K, Sisto T, et al. Preoperative levosimendan infusion in combined aortic valve and coronary bypass surgery. Br J Anaesth 2011; 106: 298-304
39. Levin RL, Degrange MA, Porcile R, et al. The calcium sensitiser levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome. Rev Esp Cardiol 2008; 61: 471-9
40. Levin R, Degrange M, Del Mazo C, Tanus E, Porcile R. Preoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass. Exp Clin Cardiol 2012; 17: 125-30
41. LillebergJ, NieminenMS, Akkila J, et al. Effects ofanewcalcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J 1998; 19: 660-8
42. Modine T, Decoene C, Al-Ruzzeh S, et al. Dobutamine improves thoracic aortic blood flow during off-pump coronary artery bypass surgery: results of a prospective randomised controlled trial. Eur J Cardiothorac Surg 2005; 27: 289-95
43. Möllhoff T, LoickHM, VanAken H, et al. Milrinonemodulates endotoxemia, systemic inflammation, andsubsequentacutephaseresponse aftercardiopulmonarybypass (CPB).Anesthesiology 1999;90: 72-80
44. Nijhawan N, Nicolosi AC, Montgomery MW, Aggarwal A, Pagel PS, Warltier DC. Levosimendan enhances cardiac performance after cardiopulmonary bypass: a prospective, randomized placebocontrolled trial. J Cardiovasc Pharmacol 1999; 34: 219-28
45. Parviainen I, Ruokonen E, Takala J. Dobutamine-induced dissociation between changes in splanchnic blood flow and gastric intramucosal pH after cardiac surgery. Br J Anaesth 1995; 74: 277-82
46. RistikankareA, Pöyhiä R, ErikssonH, ValtonenM, LeinoK, Salmenperä M. Effects of levosimendan on renal function in patients undergoing coronaryartery surgery. J Cardiothorac Vasc Anesth 2012; 26: 591-5
47. ShahB, SharmaP, Brahmbhatt A, et al.Studyof levosimendanduringoffpumpcoronaryartery bypass grafting in patients with LV dysfunction: a double-blind randomized study. Indian J Pharmacol 2014; 46: 29-34
48. Sharma P, Malhotra A, Gandhi S, Garg P, Bishnoi A, Gandhi H. Preoperative levosimendanin ischemic mitral valve repair. Asian Cardiovasc Thorac Ann 2013; 0: 1-7
49. Shi Y, Denault AY, Couture P, Butnaru A, Carrier M, Tardif JC. Biventricular diastolic filling patterns after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 2006; 131: 1080-6
50. SongJW, JoYY, JunNH, KimHK, KwakYL. Theeffect of milrinoneonthe intraoperative hemodynamics during off-pump coronary bypass surgery in patients with an elevated echocardiographic index of the ventricular filling pressure. Korean J Anesthesiol 2011; 60: 185-91
51. Tritapepe L, De Santis V, Vitale D, et al. Preconditioning effects of levosimendan in coronary artery bypass grafting-a pilot study. Br J Anaesth 2006; 96: 694-700
52. Tritapepe L, De Santis V, Vitale D, et al. Levosimendan pretreatment improves outcomes in patients undergoing coronary artery bypass graft surgery. Br J Anaesth 2009; 102: 198-204
53. van der Maaten JM, de Vries AJ, Rietman GW, Gallandat Huet RC, De Hert SG. Effects of preemptive enoximone on left ventricular diastolic function after valve replacement for aortic stenosis. J Cardiothorac Vasc Anesth 2007; 21: 357-66
54. Greco T, Landoni G, Biondi-Zoccai G, D'Ascenzo F, Zangrillo A. A Bayesian network meta-analysis for binary outcome: how to do it. Stat Methods Med Res Advance Access published on 28 October, 2013
55. Greco T, Landoni G, Saleh O, Zangrillo A. Case study in anesthesia and intensive care. In: Biondi-Zoccai G, ed. Network Meta-Analysis: Evidence Synthesis with Mixed Treatment Comparison. Hauppauge, NY: Nova Science Publishers, 2014; 263-81
56. Landoni G, Mizzi A, Biondi-Zoccai G, et al. Reducing mortality in cardiac surgery with levosimendan:ameta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth 2010; 24: 51-7
57. Landoni G, Biondi-Zoccai G, Greco M, et al. Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies. Crit Care Med 2012; 40: 634-46
58. Cleland JGF, TakalaA, Apajasalo M, Zethraeus N, Kobelt G. Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial. Eur J Heart Fail 2003; 5: 101-8
59. De Lissovoy G, Fraeman K, Teerlink JR, et al. Hospital costs for treatment of acute heart failure: economic analysis of the REVIVE II study. Eur J Health Econ 2010; 11: 185-93
60. Biondi-Zoccai G, Lotrionte M, Landoni G, Modena MG. The rough guide to systematic reviews and meta-analyses. HSR Proc Intensive Care Cardiovasc Anesth 2011; 3: 161-73
61. Biondi-Zoccai G, Landoni G, Modena MG. A journey into clinical evidence: from case reports to mixed treatment comparisons. HSR Proc Intensive Care Cardiovasc Anesth 2011; 3: 93-6
62. Greco T, Zangrillo A, Biondi-ZoccaI G, Landoni G. Meta-analysis: pitfalls and hints. Heart, Lung and Vessels 2013; 5: 219-22